Beihai Gofar Chuanshan Biological (600538.SH) director Wu Peicheng plans to spend 2 to 4 million yuan to increase holdings.
Guofa Group (stock code: 600538.SH) announces that Mr. Wu Peicheng, a director of the company, plans to resign from January 20, 2025...
Beihai Gofar Chuanshan Biological (600538.SH) announced that Mr. Wu Peicheng, a director of the company, plans to increase his shareholding in the company through concentrated trading starting from January 20, 2025 for a period of 6 months. The amount of increase shall not be less than 2 million yuan and not exceed 4 million yuan.
Related Articles

Tianqi Lithium Corporation (09696) plans to sell no more than 1.25% of its equity in SQM.

Brokerage Morning Meeting Highlights | Global commercial aerospace enters a new stage with scale deployment and ecosystem construction as the core.

Alibaba Qianwen Launches Open Source Weighted Language Model Qwen3-Coder-Next
Tianqi Lithium Corporation (09696) plans to sell no more than 1.25% of its equity in SQM.

Brokerage Morning Meeting Highlights | Global commercial aerospace enters a new stage with scale deployment and ecosystem construction as the core.

Alibaba Qianwen Launches Open Source Weighted Language Model Qwen3-Coder-Next

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


